Genmab | GEN - Market Capitalization

Stock Price
2,097.00
Daily Change
7.00 0.33%
Monthly
4.33%
Yearly
51.08%
Q1 Forecast
1,920.90

Genmab reported DKK133.89B in Market Capitalization this February of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.33B 402M Sep/2025
Almirall EUR 2.29B 527.4M Jun/2025
Amarin USD 341M 4M Sep/2025
Amgen USD 185.28B 33.35B Feb/2026
argenx SE USD 44.32B 15.63B Sep/2025
AstraZeneca USD 233.07B 17.56B Sep/2025
Bayer EUR 27.23B 2.14B Sep/2025
BioMarin Pharmaceutical USD 10.4B 142M Sep/2025
Demant DKK 42.81B 3.2B Feb/2026
Exelixis USD 10.79B 1.79B Sep/2025
Fresenius Medical Care EUR 13.1B 1.17B Sep/2025
Galapagos EUR 1.92B 355.84M Sep/2025
Genmab DKK 80.88B 7.82B Jun/2025
GlaxoSmithKline GBP 64.04B 7.8B Sep/2025
GN Store Nord DKK 16.21B 1.49B Sep/2025
GRIFOLS EUR 7.49B 1.16B Sep/2025
Hikma Pharmaceutical USD 6.06B 1.64B Jun/2025
Insmed USD 30.44B 11.35B Sep/2025
Lonza CHF 39.68B 980.61M Jun/2025
Merck EUR 47.59B 239.13M Sep/2025
Novartis USD 265.66B 9.48B Sep/2025
Regeneron Pharmaceuticals USD 81.12B 21.53B Dec/2025
Roche Holding CHF 266.34B 55.46B Dec/2025
Sanofi EUR 100.88B 4.46B Dec/2025
UCB EUR 32.47B 4.91B Jun/2025